Vanguard Group’s Oruka Therapeutics ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $20.4M | Buy |
|
|||||
|
2025
Q1 | $16.8M | Buy |
|
|||||
|
2024
Q4 | $31.2M | Buy |
|
|||||
|
2024
Q3 | $926K | Sell |
|
|||||
|
2024
Q2 | $1.74M | Hold |
|
|||||
|
2024
Q1 | $798K | Hold |
|
|||||
|
2023
Q4 | $771K | Buy |
|
|||||
|
2023
Q3 | $906K | Sell |
|
|||||
|
2023
Q2 | $937K | Sell |
|
|||||
|
2023
Q1 | $930K | Buy |
|
|||||
|
2022
Q4 | $1.09M | Buy |
|
|||||
|
2022
Q3 | $946K | Sell |
|
|||||
|
2022
Q2 | $1.15M | Buy |
|
|||||
|
2022
Q1 | $1.06M | Buy |
|
|||||
|
2021
Q4 | $874K | Sell |
|
|||||
|
2021
Q3 | $1.24M | Buy |
|
|||||
|
2021
Q2 | $1.39M | Buy |
|
|||||
|
2021
Q1 | $502K | Buy |
|
|||||
|
2020
Q4 | $351K | Buy |
|
|||||
|
2020
Q3 | $62K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $19K | Hold |
|
|||||
|
2018
Q4 | $17K | Sell |
|
|||||
|
2018
Q3 | $29K | Buy |
|
|||||
|
2018
Q2 | $22K | Buy |
|
|||||
|
2018
Q1 | $18K | Sell |
|
|||||
|
2017
Q4 | $138K | Sell |
|
|||||
|
2017
Q3 | $122K | Buy |
|
|||||
|
2017
Q2 | $177K | Sell |
|
|||||
|
2017
Q1 | $304K | Hold |
|
|||||
|
2016
Q4 | $347K | Hold |
|
|||||
|
2016
Q3 | $351K | Hold |
|
|||||
|
2016
Q2 | $353K | Hold |
|
|||||
|
2016
Q1 | $417K | Buy |
|
|||||
|
2015
Q4 | $553K | Buy |
|
|||||
|
2015
Q3 | $434K | Buy |
|
|||||
|
2015
Q2 | $619K | Buy |
|
|||||
|
2015
Q1 | $362K | Buy |
|
|||||
|
2014
Q4 | $401K | Buy |
|
|||||
|
2014
Q3 | $505K | Buy |
|
|||||
|
2014
Q2 | $584K | Buy |
|
|||||
|
2014
Q1 | $721K | Buy |
|
|||||
|
2013
Q4 | $292K | Buy |
|
|||||
|
2013
Q3 | $257K | Buy |
|
|||||
|
2013
Q2 | $13K | Buy |
|